Antigens and cytokine genes in antitumor vaccines: The importance of the temporal delivery sequence in antitumor signals

Annals of the New York Academy of Sciences

Volumn 1091, Issue , 2006, Pages 412-424

  Herrero, María José ^a   Botella, Rafael ^b   Dasí, Francisco ^a   Algás, Rosa ^c   Sánchez, María ^a   Aliño, Salvador F ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Cell vaccine; Gene transfer; GM CSF; Melanoma; Tumor antigen

Indexed keywords

CANCER ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELANOMA VACCINE; MEMBRANE PROTEIN; TUMOR ANTIGEN; CANCER VACCINE; CYTOKINE;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNIZATION; CANCER INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; GENE TRANSFER; IMMUNE RESPONSE; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; C57BL MOUSE; CANCER TRANSPLANTATION; EXPERIMENTAL MELANOMA; GENETICS; IMMUNOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CELL LINE, TUMOR; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY, ADOPTIVE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION;

EID: 33947582051     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.084     Document Type: Conference Paper

References (12)

1. DUNUSSI-JOANNOPOULOS, K., G. DRANOFF, H.J. WEINSTEIN, et al. 1998. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines. Blood 91: 222-230.
2. MASTRANGELO, M.J. & E.C. LATTIME. 2002. Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors. Cancer Gene Ther. 9: 1013-1021.
3. SE-HEON, K., J.F. CAREW, D.A. KOOBY, et al. 2000. Cancer Gene Ther. 7: 1279-1285.
4. BORRELLO, I. & D. PARDOLL. 2002. Cytokine and Growth Factor Rev. 13: 185-193.
5. JAFFEE, E.M., R. ABRAMS, J. CAMERON, et al. 1998. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GMCSF gene for the treatment of pancreatic adenocarcinoma. Human Gene Ther. 9: 1951-1971.
6. SERAFINI, P., R. CARBLEY, K.A. NOONAN, et al. 2004. High-dose granulocytemacrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64: 6337-6343.
7. RODRÍGUEZ-LECOMPTE, J.C., S. KRUTH, et al. 2004. Cell-based cancer gene therapy: breaking tolerance or inducing autoimmunity? Anim. Health Res. Rev. 5: 227-234.
8. SHI, F.S., S. WEBER, J. GAN, et al. 1999. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF. Cancer Gene Ther. 6: 81-88.
9. MORET-TATAY, I., J. DIAZ, F.M. MARCO, et al. 2003. Complete tumor prevention by engineered tumor cell vaccines employing nonviral vactors. Cancer Gene Ther. 10: 887-897.
10. GUILLEM, V.M. & S.F. ALIÑO. 2004. Transfection pathways of nonspecific and targeted PEI-polyplexes. Gene Ther. Mol. Biol. 8: 369-384.
11. BORDIER, C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 25: 1604-1607.
12. BOTELLA-ESTRADA, R., F. DASÍ, D. RAMOS, et al. 2005. Cytokine expression and dendritic cell density in melanoma sentinel nodes. Melanoma Res. April: 99-106.